Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy.

Ru WangBin WangHuimin ZhangXiaoqin LiaoBohui ShiYuhui ZhouCan ZhouYu YanWei ZhangKe WangGuanqun GeYu RenXiaojiang TangBaoyu GanJianjun HeLigang Niu

Published in: Breast (Edinburgh, Scotland) (2024)

Early changes of ctDNA are strongly correlated with therapeutic efficacy to PST and clinical outcomes in BC patients. The integration of preoperative ctDNA evaluation could help improving the perioperative management for BC patients receiving PST.

Keyphrases

circulating tumor
cell free
circulating tumor cells
end stage renal disease
patients undergoing
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
cardiac surgery
acute kidney injury
patient reported outcomes
patient reported
bone marrow